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Fibroblast growth factor 10 is a novel member of the
®broblast growth factor family, which is involved in
morphogenesis and epithelial proliferation. It is
highly homologous to the keratinocyte growth factor
(or ®broblast growth factor 7), a key mediator of
keratinocyte growth and differentiation. Both ®bro-
blast growth factor 10 and keratinocyte growth fac-
tor bind with high af®nity to the tyrosine kinase
keratinocyte growth factor receptor. Here we ana-
lyzed the effect of ®broblast growth factor 10 on pri-
mary cultures of human keratinocytes, grown in
chemically de®ned medium, and we compared the
proliferative and differentiative cell responses to
®broblast growth factor 10 with those induced by
keratinocyte growth factor and epidermal growth
factor. Cell counting, 5-bromo-2¢-deoxyuridine
incorporation, and western blot analysis showed that
®broblast growth factor 10, similarly to keratinocyte
growth factor, not only is a potent mitogen for
human keratinocytes, but also promotes the expres-
sion of both early differentiation markers K1 and
K10 and late differentiation marker ®laggrin in
response to the Ca2+ signal, and seems to sustain the
proliferative activity in suprabasal strati®ed cells.
Immunoprecipitation/western blot analysis revealed
that ®broblast growth factor 10, similarly to kerati-
nocyte growth factor, is able to induce tyrosine
phosphorylation of keratinocyte growth factor recep-
tor and of cellular substrates such as PLCg. Key
words: ®broblast growth factor 10/human keratinocytes/
keratinocyte growth factor. J Invest Dermatol 116:623±628,
2001
T
he ®broblast growth factors (FGF) constitute a family
of at least 19 members and are responsible for different
activities on cell proliferation and differentiation,
embryonic development, angiogenesis, and wound
healing (for a review, see Mason, 1994). FGF-10 is a
novel member of the FGF family, whose biologic activities remain
to be elucidated (Yamasaki et al, 1996; Emoto et al, 1997). It has
recently been reported that FGF-10 plays a key role in controlling
directional outgrowth and inducing epithelial buds in lung
development (Bellusci et al, 1997; Park et al, 1998). Moreover,
FGF-10, together with other members of the FGF family, appears
to be essential for signaling induction during limb development
(Xu et al, 1998). Finally, generation of FGF-10 de®cient mice leads
to lack of both limb and lung formation (Min et al, 1998; Sekine et
al, 1999).
When compared to the other members of the FGF family, both
the amino acid sequence and the tissue expression of FGF-10 show
high similarity to those of the keratinocyte growth factor (KGF/
FGF-7). Unlike the other known FGF, KGF acts speci®cally on
epithelial cells (Finch et al, 1989), modulating their growth and
differentiation. In fact, KGF not only is a mitogen for murine
(Rubin et al, 1989; Duglosz et al, 1994) and human cultured
keratinocytes (Marchese et al, 1990), but also promotes their early
differentiation program (Marchese et al, 1990; 1997) and inhibits
their terminal differentiation and apoptosis (Hines and Allen-
Hoffman, 1996). In addition, KGF seems to play a key role in
reepithelialization during normal human and experimental wound
healing (Werner et al, 1992, 1994; Staiano-Coico et al, 1993;
Marchese et al, 1995). Similarly to KGF, FGF-10 seems to exert
mitogenic activity on mouse and rat keratinocyte cell lines (Emoto
et al, 1997; Igarashi et al, 1998). Expression of FGF-10 does not
seem to be modulated, however, during experimental wound
healing (Beer et al, 1997), although the topical addition of the
growth factor promotes wound repair in the same model (Jimenez
and Rampy, 1999).
Both FGF-10 and KGF bind only and with high af®nity (Igarashi
et al, 1998) to the KGF receptor (KGFR), a splicing variant of FGF
receptor 2 (FGFR2), expressed exclusively on epithelial cells (Miki
et al, 1991, 1992). The two growth factors show a different
sensitivity to heparin in their mitogenic activity, however, implying
that the extracellular matrix may play a role in regulating the
cellular response to FGF-10 and KGF (Igarashi et al, 1998).
We have recently shown that KGFR is up-modulated in vitro
during differentiation from basal to suprabasal keratinocytes
(Marchese et al, 1997), suggesting that receptor expression may
control the proliferative±differentiative cell program, and consistent
with the ability of KGF, unlike the epidermal growth factor (EGF),
to induce both cell proliferation and expression of differentiation
markers in response to the Ca2+ signal (Marchese et al, 1990, 1997).
To ascertain if FGF-10 is able to exert activities similar to KGF on
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primary cultures of human keratinocytes, we compared here the
proliferative and differentiative cell response to FGF-10, KGF, and
EGF. Our results show that FGF-10 is a potent mitogen for human
keratinocytes. In addition, similarly to KGF and differently from
EGF, FGF-10 allows the expression of the early suprabasal
differentiation markers K1 and K10 and of the late differentiation
marker ®laggrin, promoting therefore the initiation and progression
of the keratinocyte maturation program.
MATERIALS AND METHODS
Human keratinocyte culture Primary cultures of human
keratinocytes derived from neonatal foreskin as previously described
(Rheinwald and Green, 1977) were maintained in MCDB 153 medium
(Clonetics, San Diego, CA), supplemented with 0.5 mg per ml
hydrocortisone, 5 mg per ml insulin, 5 mg per ml gentamycin, and 70 mg
per ml whole bovine pituitary extract. Ca concentration in the medium
was maintained at 0.15 mM (Boyce and Ham, 1983). Cell adhesion was
achieved by precoating the tissue culture 24-well plates used for the
proliferation assay with 1 mg per ml of ®bronectin (Sigma Chemical, St.
Louis, MO). Cultures were supplemented with recombinant human
FGF-10 (Igarashi et al, 1998) (0.05±5 mM, 1±100 ng per ml), with EGF
(0.05±5 mM, 3±300 ng per ml; Collaborative Research, Lexington,
MA), or with KGF (0.05±5 mM, 1.4±140 ng per ml; Upstate
Biotechnology, Lake Placid, NY). To measure cell number, cultures
were harvested by incubation in 0.5% trypsin, 0.2% ethylenediamine
tetraacetic acid (EDTA) for 15 min at 37°C, and the cell counts were
performed in triplicate using a hemocytometer.
5-Bromo-2¢-deoxyuridine (BrdU) incorporation and immuno-
¯uorescence Cells, grown on tissue culture chamber slides (Nunc,
Naperville, IL), were treated for 3 d with each growth factor at a
concentration of 20 ng per ml. At the end of treatment, 100 mM BrdU
(Sigma) was added to the medium and the cultures were incubated for
24 h at 37°C to allow BrdU incorporation. Cells were then ®xed in 4%
formaldehyde in phosphate-buffered saline (PBS) for 30 min at 25°C,
followed by treatment with 0.1 M glycin for 20 min at 25°C and with
0.5% HCl, 0.1% Triton X-100 for an additional 45 min at 25°C to
allow permeabilization. After extensive washing in PBS, cells were
buffered with 0.1 M Na2B4O7 and incubated with anti-BrdU
monoclonal antibody (Sigma) (1:50 in blocking buffer: PBS 0.5% bovine
serum albumin, 0.5% Tween 20) for 30 min at 25°C in a humidity
chamber, followed by goat antimouse IgG-Texas Red (1:50 in blocking
buffer) (Jackson Immuno Research Laboratories, PA). For double
immuno¯uorescence, cells were incubated with anti-BrdU as above and
with anti-K1 polyclonal antibodies (Berkeley Antibody, Richmond, CA)
(1:100 in PBS) visualized with goat antimouse IgG-¯uorescein
isothiocyanate (1:10 in PBS) (Cappel Research Products, Durham, NC)
and goat antirabbit IgG-Texas Red (1:50 in PBS) (Jackson Immuno
Research Laboratories) after appropriate washing with PBS.
Colocalization of the two ¯uorescence signals was analyzed by recording
and merging single stained images using a cooled CCD color digital
camera SPOT-2 (Diagnostic Instruments, MI) and FISH 2000/H1
software (Delta Sistemi, Roma, Italy).
Western blot analysis Cells cultured for 6 d in medium containing
1 mM Ca2+ concentration and supplemented with 20 ng per ml FGF-
10, KGF, or EGF were lyzed in RIPA buffer [10 mM Tris, pH 7.4;
50 mM NaCl; 1 mM EDTA; 10 mM KCl; 1% Nonidet P-40; 0.1%
sodium dodecyl sulfate (SDS); 0.05% Tween 20] supplemented with
protease inhibitors [10 mg per ml aprotinin, 1 mM phenylmethylsulfonyl
¯uoride (PMSF), 10 mg per ml leupeptin]. Twenty-®ve micrograms of
total proteins were resolved under reducing conditions by 10% SDS
polyacrylamide gel electrophoresis (PAGE) and transferred to reinforced
nitrocellulose (PROTRAN, Schleider & Schuell, Keene, NH). The
membrane was blocked with 3% nonfat dry milk in PBS with 0.05%
Tween 20 for 4 h at room temperature. After washing for 20 min in
PBS 0.05% Tween 20, the membrane was incubated with anti-K1
polyclonal antibody diluted 1:500 (Berkeley Antibody), with anti-K10/
13 mouse monoclonal antibody diluted 1:200 (Santa Cruz
Biotechnology, Santa Cruz, CA), and with anti®laggrin monoclonal
antibody diluted 1:500 (Biomedical Technologies, Stoughton, MA) for
1 h at 25°C, followed by enhanced chemiluminescence (ECL) detection
(Amersham, Arlington Heights, IL).
Figure 1. Comparison of the proliferative activities of FGF-10 (in the presence or absence of 0.3 mg per ml heparin), KGF, and EGF on
human primary cultured keratinocytes grown in standard low Ca2+ medium. Treatments and cell counts were performed as described in
Materials and Methods. The results represent the mean values from three different experiments.
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Immunoprecipitation and western blot analysis Subcon¯uent
cultures of NIH3T3 KGFR transfectants were lyzed in RIPA buffer
(10 mM Tris pH 7.4; 50 mM NaCl; 1 mM EDTA; 10 mM KCl; 1%
Nonidet P-40; 0.1% SDS; 0.05% Tween 20) supplemented with protease
inhibitors (10 mg per ml aprotinin, 1 mM PMSF, 10 mg per ml
leupeptin) and phosphatase inhibitors (25 mM sodium orthovanadate,
20 mM sodium pyrophosphate, 0.5 M NaF). Fifteen micrograms of total
proteins were resolved under reducing conditions by 7% SDS-PAGE and
transferred to reinforced nitrocellulose (BA-S 83, Schleider & Schuell).
The membrane was blocked with 5% nonfat dry milk in PBS with 0.1%
Tween 20 for 4 h at room temperature. After washing for 20 min in
PBS 0.1% Tween 20 the membrane was incubated alternatively with
rabbit anti-Bek polyclonal antibodies, diluted 1:200 (C-17, Santa Cruz
Biotechnology), or with mouse anti-Bek monoclonal antibody, diluted
1:200 (C-8, Santa Cruz Biotechnology), both antibodies raised against
the carboxy terminal region of the intracellular domain of the FGFR2/
KGFR, for 1 h at 25°C, followed by ECL detection (Amersham). For
the detection of KGFR tyrosine phosphorylation, NIH3T3 KGFR cells
were serum starved for 12 h, treated with 100 ng per ml KGF 0.3 M
NaCl or with 100 ng per ml FGF-10 for 10 min at 37°C, lyzed, and
processed as above for immunoblotting with antiphosphotyrosine
monoclonal antibody diluted 1:1000 (Upstate Biotechnology). For
immunoprecipitation/immunoblotting experiments, cell were lyzed in
1% Triton X100, 50 mM HEPES buffer containing 150 mM NaCl, 1%
glycerol, 1.5 mM MgCl2, 5 mM ethyleneglycol-bis(b-aminoethyl ether)-
N,N,N¢,N¢-tetraacetic acid, and protease and phosphatase inhibitors as
above. A hundred micrograms of total protein were immunoprecipitated
with 4 mg per ml anti-Bek antibodies. Immunocomplexes aggregated
with 50 ml of g bind Protein-G Sepharose (Pharmacia, Uppsala, Sweden)
were washed four times with 0.6 ml of buffer. The pellets were boiled
in Laemmli buffer for 5 min and proteins were resolved under reducing
conditions by 10% SDS-PAGE and transferred to reinforced
nitrocellulose (PROTRAN, Schleider & Schuell). The membrane was
blocked with 3% bovine serum albumin in PBS (0.05% Tween 20)
overnight and probed for 1 h with antiphosphotyrosine antibody,
followed by ECL detection.
For the detection of phospholipase Cg (PLCg), the nitrocellulose used
for the experiment of immunoprecipitation/immunoblotting described
above was stripped for 30 min at 55°C with 100 mM mercaptoethanol,
2% SDS, and 62.5 mM Tris pH 6.7, washed for 15 min in PBS 0.1%
Tween 20 at room temperature, and blocked with 5% nonfat dry milk in
PBS/Tween for 1 h. The membrane was then incubated with mono-
clonal antibody anti-PLCg 2 mg per ml (Upstate Biotechnology) for 1 h
at room temperature followed by ECL detection.
RESULTS
Proliferation of human keratinocytes in response to FGF-10,
KGF, and EGF To analyze the possible mitogenic effect of
FGF-10 on primary cultures of human keratinocytes and to
compare the proliferative response induced by FGF-10 with that of
KGF and EGF, we plated the cells at a density of 2 3 105 per well
and grew them for 6 d in standard medium supplemented with
varying concentrations of the growth factors. As it has recently
been shown that the biologic activity of FGF-10 on a mouse
keratinocyte cell line is highly dependent on heparin and that the
optimal concentration of heparin required for maximal DNA
synthesis is 0.3 mg per ml (Igarashi et al, 1998), we used this heparin
concentration in our dose±response curve of FGF-10 proliferation
Figure 2. BrdU incorporation in keratinocyte
cultures grown in standard low Ca2+
medium and supplemented with FGF-10,
KGF, EGF, or kept in medium alone.
Immuno¯uorescence with anti-BrdU antibodies
reveals that in FGF-10-treated and in KGF-treated
cultures most of the cell nuclei were positively
stained, compared with a lower number in EGF-
treated cells and the minority in control untreated
cells. In both FGF-10- (A, B) and KGF-
supplemented (C, D) cultures, but not in EGF-
treated (E, F) or untreated (G, H) cultures, BrdU
staining was not con®ned to basal cell nuclei but
appeared also on suprabasal cells (A, C, arrows), as
shown in parallel phase contrast images (B, D).
Scale bar: 10 mm.
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(Fig 1). Addition of FGF-10 was also performed in the absence of
heparin. A signi®cant increase in cell number (approximately 5-
fold) was already detectable at low concentration of the growth
factor (0.05 nM) and the maximal mitogenic activity (7-fold
increase) was observed at a concentration of 0.5 nM FGF-10.
Comparison of the increases in cell number obtained in response to
the growth factors revealed that FGF-10 induced the greatest
proliferation in our culture conditions and con®rmed the heparin
requirement for optimal mitogenic activity (Fig 1). Thus FGF-10
appears to represent a novel potent mitogen for primary cultures of
human keratinocytes.
To con®rm the ability of FGF-10 to stimulate DNA synthesis in
primary cultures of human keratinocytes and to identify the
proliferating cells in the growing colonies kept at a standard low
concentration of Ca2+ (0.15 mM), we performed a BrdU incorp-
oration assay and observed the labeled nuclei at immuno¯uores-
cence. Cells, treated with each growth factor for 3 d, were
incubated with BrdU for 24 h at 37°C and ®xed in formaldehyde;
incorporated BrdU was then visualized with anti-BrdU antibody
followed by Texas Red-conjugated secondary antibodies. In
untreated control keratinocytes, grown in standard medium and
plated at low cell density, only a minority of the cells (approxi-
mately 20%) showed nuclei positively stained for BrdU (Fig 2G).
Parallel phase contrast microscopy revealed colonies small in size
and in cell number and composed mostly of basal cells (Fig 2H).
When keratinocyte cultures were exposed to FGF-10 (Fig 2A, B),
KGF (Fig 2C, D), or EGF (Fig 2E, F) before BrdU incorporation,
most of the cells (approximately 80% of FGF-10-treated cells, 70%
of KGF-treated cells, and 50% of EGF-treated cells) showed intense
BrdU staining in the nuclei. Parallel phase contrast observation of
cultures treated with FGF-10 and KGF showed large colonies
characterized by an evident increase in size and in cell number
compared to the untreated cultures; in addition, in FGF-10- and
KGF-treated cultures, the colonies were composed not only of
basal but also of suprabasal cells (Fig 2B, D). Moreover, in FGF-
10-treated and KGF-treated cultures, BrdU staining was not
con®ned to basal cell nuclei but appeared also on suprabasal
strati®ed cells, superimposed on the basal ones (Fig 2A, C, arrows).
The differentiated nature of the suprabasal cells positive for BrdU
was unequivocally demonstrated by double immuno¯uorescence
with anti-K1 polyclonal antibodies (Fig 3). In control experiments,
performed by omission of BrdU from the culture medium during
the 24 h incubation, the cell nuclei were all negative. Thus, FGF-
10 and KGF, but not EGF, appear to promote the initial
strati®cation of keratinocytes in vitro and to sustain their
proliferative activity also in cells located suprabasally.
Effect of FGF-10 on the expression of K1, K10, and ®laggrin
differentiation markers Basal keratinocytes committed to the
differentiation program are known to become suprabasal and to
express the early differentiation markers K1 and K10 and then the
late differentiation marker ®laggrin (for a review see Fuchs, 1990).
EGF blocks the in vitro expression of K1 and ®laggrin induced by
high concentrations of Ca2+, whereas KGF seems to promote such
expression (Marchese et al, 1990, 1997). To analyze the effect of
FGF-10, compared with KGF and EGF, on keratinocyte
differentiation, we exposed keratinocyte cultures to the Ca2+
differentiation signal (1.0 mM Ca2+) in the presence of the growth
factors. Western blot analysis with anti-K1, anti-K10, and
anti®laggrin antibodies showed that both the K1 and K10 early
proteins and the late differentiation protein ®laggrin were expressed
in FGF-10 supplemented cultures as well as in KGF-treated and in
control untreated cultures; in contrast, the expression of the two
keratins and of ®laggrin was highly inhibited by treatment with
EGF, as expected (Fig 4) (Marchese et al, 1990, 1997). Thus,
FGF-10, similarly to KGF, promotes the expression of both early
and late differentiation markers in response to the Ca2+ signal.
Tyrosine phosphorylation and activation of KGFR induced
by FGF-10 binding To analyze the effects of FGF-10,
compared to KGF, on the phosphorylation of KGFRs, we
treated KGFR transfected NIH3T3 cells with FGF-10 (100 ng
per ml) or with KGF (100 ng per ml) for 10 min at 37°C. Cell
lysates were immunoprecipitated with anti-Bek polyclonal
antibodies, which speci®cally recognize the intracellular domain
shared by the two splicing isoforms, FGFR2 and KGFR, followed
by immunoblotting with antiphosphotyrosine monoclonal
antibody. FGF-10 binding to KGFR induced phosphorylation of
a protein species reacting with anti-Bek antibodies and
corresponding to the molecular weight of the KGFR (Fig 5), as
expected (Marchese et al, 1998), and no reactivity was detected in
control nontransfected NIH3T3 cells (data not shown). Similar
tyrosine phosphorylation of KGFR was induced by treatment with
KGF; a weak tyrosine phosphorylation of KGFR was detected also
in untreated cells (Fig 5), most likely as a consequence of autocrine
Figure 3. BrdU incorporation and K1
expression in human keratinocytes cultured
in standard low Ca2+ medium and
supplemented with FGF-10, KGF, or EGF,
or kept in medium alone. Double
immuno¯uorescence with anti-BrdU (green) and
anti-K1 (red) antibodies show codistribution of
the nuclear BrdU staining and the cytosolic K1
signal by overlapping single images in FGF-10-
(A) or KGF-supplemented (B) cultures, but not in
EGF-stimulated (C) or untreated control (D)
cultures. Arrows in (A) and (B) point to suprabasal
cells positive for BrdU and expressing K1. Scale
bar: 40 mm.
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receptor activation, as NIH3T3 cells are known to produce mouse
KGF (Miki et al, 1991). The addition of heparin (0.3 mg per ml) to
FGF-10 when used at a concentration of 100 ng per ml did not
increase the KGFR phosphorylation (data not shown), in
agreement with the similar mitogenic activity of FGF-10 at
100 ng per ml in the presence or absence of heparin, as reported by
Igarashi et al (1998). Moreover, both FGF-10 and KGF stimulated
phosphorylation of a 150 kDa protein, which coimmuno-
precipitated with the activated KGFR (Fig 5) and which was
identi®ed, by stripping and reprobing the same nitrocellulose with
anti-PLCg antibody, as the PLCg protein (Fig 5). This result
con®rms that PLCg is a major substrate of the KGFR (Shaoul et al,
1995) and demonstrates that FGF-10, similarly to KGF, induces not
only phosphorylation but also signaling by the KGFR.
DISCUSSION
The process of growth and differentiation of epidermis appears to
be ®nely regulated by the action of several autocrine and paracrine
factors with overlapping speci®cities and functions (Fuchs, 1990).
This regulation results in both the proliferation of basal cells and the
triggering of terminal differentiation. The use of human keratino-
cytes, which can be cultured in chemically de®ned medium,
permits analysis in a controlled model system of the activity of
single growth factors selectively added to the culture. In this study,
we analyzed the effect of the newly identi®ed FGF-10 on cultured
human keratinocytes, comparing its activities with those exerted by
the homolog KGF and by EGF. As KGF elicits a peculiar response
on cultured keratinocytes, positively modulating both their prolif-
eration and early differentiation, and as KGFR appears to be up-
modulated during differentiation, we were interested to analyze if
also FGF-10, being highly homologous to KGF and having similar
receptor speci®city, might induce such a response. Our results
indicate that FGF-10 exerts both proliferative and differentiative
activity on human keratinocytes similar to that of KGF and suggest
that FGF-10 may play an important role as a positive regulator of
epidermal growth and differentiation in vivo and in vitro.
The BrdU incorporation assay applied in this study allowed us to
identify the proliferating cells in cultures treated with the growth
factors. Interestingly, in FGF-10-treated cultures, as well as in
KGF-treated cultures, keratinocytes appear to be not only triggered
to become suprabasal, consistent with the expression of K1 and K10
differentiation markers, but also induced to maintain a DNA
synthesis capacity when located suprabasally. This ®nding parallels
the observation that KGFR are expressed on suprabasal differen-
tiated cells (Marchese et al, 1997, 1998) and that KGF, unlike EGF,
exerts a mitogenic effect on con¯uent cells, which are therefore
committed to differentiate (Hines and Allen-Hoffman, 1996).
Work is in progress to de®ne the different functions and signaling
properties of the receptors for both ligands KGF and FGF-10,
when present on basal or suprabasal cells, and to elucidate the
mechanism of action of the two growth factors in normal epidermal
tissues as well as in hyperplastic skin diseases and during human
wound healing.
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